[ad_1]
The Stockholm Stock Exchange opened on Friday with a recovery after the global recovery since Bloomberg announced that US President Donald Trump had asked the Cabinet to set the terms for a possible trade deal with China.
Fund processing company Loomis has seen strong growth. Medical engineering company Getinge recycled after the company commented on data that the FDA of the US Health Authority was reviewing reports of deficiencies in aortic pallet pumps from one of Getinge's subsidiaries .
At 10:10, the OMXS30 grew by nearly 1.2% to 1.549. The turnover amounted to 3.1 billion SEK.
Even in the main European stock exchanges, the talks were positive and the DAX rose by 1.2%, the FTSE 100 by 1.0% and in Paris, the CAC40 rose by 1.3%.
US stock markets gained between 1.1% and 1.8% Thursday night and US futures continued to grow. In Asia, Japan's Nikkei index rose 2.6%, while China's Hang Seng grew 4.2%.
Donald Trump and Chinese President Xi Jinping spoke on Thursday, a call the US president called "far and very good". After the conversation, he asked a number of ministers to draft the terms of a possible trade agreement, a sign of a ceasefire in the trade dispute.
Larry Kudlow, White House economic advisor, said Thursday that Trump and Xi should be able to resolve some issues at the G20 meeting in Argentina at the end of November.
The data on improved tones in the US-China negotiations also saw a rise in base metal prices. On the Stockholm Stock Exchange, the industrials and commodities sectors experienced strong growth: Lundin Mining rose by 3.8%, Stora Enso by 3.5% and SSAB by 2.8%.
The cash management company left Loomis with a report that had increased by 4.5%. Ebita's operating profit amounted to SEK 626 million in the third quarter. According to Infront Data, the average of four analysts was SEK 608 million. Revenues exceeded average forecasts, although organic growth was a bit heavier than the average estimate.
The share of medical technology company Getinge rebounded from just over 5% at the opening session on Friday. The fact that the US health authority, the FDA, is reviewing reports of failures of aortal pallet pumps from a Getinge subsidiary is a "normal process," the company said. company after the Swedish closure on Thursday. Getinge dropped 8% Thursday in FDA's data traces. Thursday afternoon, Lars Sandström, financial manager of Getinge, bought shares of the company for an amount of SEK 0.24 million.
The biotech biotech company has rushed over 16% after announcing that its US partner, Abbvie, was using its option to obtain a license for the alpha-synuclein antibody portfolio in accordance with an agreement reached in 2016 This option is subject to competition in the United States. A positive result of the competitive test involves the expiry of a payment in installments of $ 50 million as part of the exercise of the license option. The cumulative total value of the license agreement can reach $ 755 million.
Verkstadsbolaget Cavotec published quarterly figures, in which after-tax profits were better than those of the previous year, but sales declined due to production problems in Italy. At the same time, the company announced a capital increase of 204 million SEK. The stock fell 11% Friday.
[ad_2]
Source link
